Arcutis Biotherapeutics Ownership 2024 | Who Owns Arcutis Biotherapeutics Now?
Institutional Ownership
113.85%
Insider Ownership
2.20%
Retail Ownership
-16.05%
Institutional Holders
190.00
Arcutis Biotherapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 10.42% | 0.07% | 11,571,694 | -604,621 | -4.97% | 107,616,756 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.01% | 3.42% | 10,004,492 | 2,127,195 | 27.00% | 93,041,776 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 8.84% | 2.39% | 9,816,672 | 2,306,672 | 30.71% | 91,295,050 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 7.91% | 3.82% | 8,785,284 | - | - | 81,703,141 | Jun 30, 2024 |
| BLACKROCK INC. | 7.76% | 0.00% | 8,622,618 | 1,963,877 | 29.49% | 80,190,347 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 6.19% | 0.38% | 6,879,072 | -6,850 | -0.10% | 63,975,370 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.53% | 0.00% | 6,144,290 | 977,873 | 18.93% | 57,141,898 | Jun 30, 2024 |
| STATE STREET CORP | 4.62% | 0.00% | 5,134,843 | -3,649,195 | -41.54% | 47,754,040,000 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 4.00% | 0.01% | 4,438,179 | -204,281 | -4.40% | 41,275,065 | Jun 30, 2024 |
| MORGAN STANLEY | 3.58% | 0.00% | 3,972,694 | -33,641 | -0.84% | 36,946,060 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 3.26% | 0.42% | 3,616,532 | -618,419 | -14.60% | 33,633,744 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.27% | 1.36% | 2,525,000 | 400,000 | 18.82% | 23,482,500 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.18% | 0.00% | 2,421,270 | 449,837 | 22.82% | 22,522,362 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.92% | 0.04% | 2,133,702 | -846,645 | -28.41% | 19,843,430 | Jun 30, 2024 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.84% | 14.59% | 2,041,108 | 13,100 | 0.65% | 18,982,304 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.69% | 0.01% | 1,882,025 | 9,420 | 0.50% | 17,502,833 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.50% | 0.14% | 1,667,979 | -53,274 | -3.10% | 15,513,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.40% | 0.34% | 1,558,500 | 808,500 | 107.80% | 14,494,050 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 1.21% | 4.54% | 1,343,609 | 403,122 | 42.86% | 12,495,564 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.18% | 0.35% | 1,311,549 | -123,769 | -8.62% | 12,197,406 | Jun 30, 2024 |
Arcutis Biotherapeutics's largest institutional shareholder is JENNISON ASSOCIATES LLC, holding 10.42% of the company's total share outstanding, currently valued at $107.62M. The top 10 institutional shareholders own together 67.87% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 1.84% | 14.59% | 2,041,108 | 13,100 | 0.65% | 18,982,304 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 1.21% | 4.54% | 1,343,609 | 403,122 | 42.86% | 12,495,564 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 7.91% | 3.82% | 8,785,284 | - | - | 81,703,141 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.01% | 3.42% | 10,004,492 | 2,127,195 | 27.00% | 93,041,776 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.87% | 2.64% | 965,392 | -1,240,507 | -56.24% | 8,978,146 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 8.84% | 2.39% | 9,816,672 | 2,306,672 | 30.71% | 91,295,050 | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | 0.06% | 1.71% | 65,147 | 65,147 | 100.00% | 605,867 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.27% | 1.36% | 2,525,000 | 400,000 | 18.82% | 23,482,500 | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | 0.69% | 1.15% | 762,190 | -47,142 | -5.82% | 7,088,367 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 0.93% | 1.05% | 1,030,703 | -980,984 | -48.76% | 9,585,538 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.44% | 0.79% | 489,642 | -100,000 | -16.96% | 4,553,672 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.75% | 0.53% | 837,847 | 837,847 | 100.00% | 7,791,977 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 3.26% | 0.42% | 3,616,532 | -618,419 | -14.60% | 33,633,744 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.15% | 0.42% | 170,900 | - | - | 1,589,370 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.14% | 0.40% | 159,626 | -476,343 | -74.90% | 1,484,522 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 6.19% | 0.38% | 6,879,072 | -6,850 | -0.10% | 63,975,370 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 1.18% | 0.35% | 1,311,549 | -123,769 | -8.62% | 12,197,406 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.40% | 0.34% | 1,558,500 | 808,500 | 107.80% | 14,494,050 | Jun 30, 2024 |
| FISHMAN JAY A LTD/MI | 0.31% | 0.34% | 346,600 | 122,300 | 54.53% | 3,223,380 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.15% | 0.28% | 163,561 | 163,561 | 100.00% | 1,521,117 | Jun 30, 2024 |
The largest Arcutis Biotherapeutics shareholder by % of total assets is PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC. The company owns 2.04M shares of Arcutis Biotherapeutics (ARQT), representing 14.59% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 8.84% | 2.39% | 9,816,672 | 2,306,672 | 30.71% | 91,295,050 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.01% | 3.42% | 10,004,492 | 2,127,195 | 27.00% | 93,041,776 | Jun 30, 2024 |
| BLACKROCK INC. | 7.76% | 0.00% | 8,622,618 | 1,963,877 | 29.49% | 80,190,347 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.18% | 0.07% | 1,307,481 | 1,307,481 | 100.00% | 12,159,006 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.53% | 0.00% | 6,144,290 | 977,873 | 18.93% | 57,141,898 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.00% | 0.07% | 1,113,582 | 891,360 | 401.11% | 10,356,000 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.75% | 0.53% | 837,847 | 837,847 | 100.00% | 7,791,977 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.40% | 0.34% | 1,558,500 | 808,500 | 107.80% | 14,494,050 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.91% | 0.01% | 1,007,384 | 790,518 | 364.52% | 9,368,671 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.45% | 0.10% | 500,000 | 500,000 | 100.00% | 350,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.66% | 0.00% | 735,042 | 486,856 | 196.17% | 6,835,891 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.18% | 0.00% | 2,421,270 | 449,837 | 22.82% | 22,522,362 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 1.21% | 4.54% | 1,343,609 | 403,122 | 42.86% | 12,495,564 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 2.27% | 1.36% | 2,525,000 | 400,000 | 18.82% | 23,482,500 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.32% | 0.00% | 359,997 | 359,997 | 100.00% | 3,347,000 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.60% | 0.09% | 667,259 | 304,390 | 83.88% | 6,205,509 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 1.16% | 0.00% | 1,285,078 | 284,872 | 28.48% | 11,951,225 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.25% | 0.00% | 273,779 | 273,779 | 100.00% | 2,546,144 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.23% | 0.00% | 257,357 | 226,258 | 727.54% | 2,393,420 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.18% | 0.00% | 203,600 | 203,600 | 100.00% | 1,893,480,000 | Jun 30, 2024 |
As of Jun 30 2024, Arcutis Biotherapeutics's largest institutional buyer is RUBRIC CAPITAL MANAGEMENT LP. The company purchased 2.31M stocks of ARQT, valued at $91.30M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 4.62% | 0.00% | 5,134,843 | -3,649,195 | -41.54% | 47,754,040,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 26,000 | -1,754,000 | -98.54% | 241,800 | Jun 30, 2024 |
| BRAIDWELL LP | - | - | - | -1,300,000 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.87% | 2.64% | 965,392 | -1,240,507 | -56.24% | 8,978,146 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 0.93% | 1.05% | 1,030,703 | -980,984 | -48.76% | 9,585,538 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 1.92% | 0.04% | 2,133,702 | -846,645 | -28.41% | 19,843,430 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -825,000 | -100.00% | - | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 3.26% | 0.42% | 3,616,532 | -618,419 | -14.60% | 33,633,744 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 10.42% | 0.07% | 11,571,694 | -604,621 | -4.97% | 107,616,756 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.23% | 0.01% | 259,478 | -562,983 | -68.45% | 2,413,145 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 14,099 | -492,187 | -97.22% | 131,153 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.14% | 0.40% | 159,626 | -476,343 | -74.90% | 1,484,522 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | - | - | - | -449,694 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.51% | 0.02% | 563,171 | -380,296 | -40.31% | 5,237,490 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -380,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.39% | 0.01% | 437,362 | -343,418 | -43.98% | 4,067,467 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.51% | 0.00% | 567,123 | -283,406 | -33.32% | 5,274,244 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -225,000 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -225,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Arcutis Biotherapeutics's biggest institutional seller is STATE STREET CORP. The company sold -3.65M shares of ARQT, valued at $47.75B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANDRIAM S.C.A. | 1.18% | 0.07% | 1,307,481 | 1,307,481 | 100.00% | 12,159,006 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 0.75% | 0.53% | 837,847 | 837,847 | 100.00% | 7,791,977 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.45% | 0.10% | 500,000 | 500,000 | 100.00% | 350,000 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.32% | 0.00% | 359,997 | 359,997 | 100.00% | 3,347,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.25% | 0.00% | 273,779 | 273,779 | 100.00% | 2,546,144 | Jun 30, 2024 |
| SWISS NATIONAL BANK | 0.18% | 0.00% | 203,600 | 203,600 | 100.00% | 1,893,480,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.18% | 0.00% | 200,000 | 200,000 | 100.00% | 1,860,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.16% | 0.01% | 175,909 | 175,909 | 100.00% | 1,635,954 | Jun 30, 2024 |
| NORGES BANK | 0.16% | 0.00% | 174,820 | 174,820 | 100.00% | 1,625,826 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.15% | 0.28% | 163,561 | 163,561 | 100.00% | 1,521,117 | Jun 30, 2024 |
| J. SAFRA SARASIN HOLDING AG | 0.12% | 0.02% | 129,560 | 129,560 | 100.00% | 1,204,908 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.09% | 0.00% | 101,289 | 101,289 | 100.00% | 941,988 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.01% | 74,300 | 74,300 | 100.00% | 690,990 | Jun 30, 2024 |
| BARCLAYS PLC | 0.06% | 0.00% | 71,700 | 71,700 | 100.00% | 667,000 | Jun 30, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | 0.06% | 1.71% | 65,147 | 65,147 | 100.00% | 605,867 | Jun 30, 2024 |
| CLOSE ASSET MANAGEMENT LTD | 0.06% | 0.02% | 64,774 | 64,774 | 100.00% | 602,000 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.06% | 0.05% | 63,093 | 63,093 | 100.00% | 586,765 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 57,156 | 57,156 | 100.00% | 531,551 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.05% | 0.07% | 56,208 | 56,208 | 100.00% | 522,734 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.05% | 0.00% | 52,600 | 52,600 | 100.00% | 488,654 | Jun 30, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | 0.05% | 0.19% | 52,244 | 52,244 | 100.00% | 485,869 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 50,444 | 50,444 | 100.00% | 470,302 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.04% | 0.07% | 45,019 | 45,019 | 100.00% | 418,677 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.04% | 0.00% | 40,500 | 40,500 | 100.00% | 376,650 | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.03% | 0.00% | 28,968 | 28,968 | 100.00% | 269,402 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.03% | 0.05% | 28,839 | 28,839 | 100.00% | 268,203 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.03% | 0.14% | 27,899 | 27,899 | 100.00% | 259,461 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.02% | 0.01% | 26,500 | 26,500 | 100.00% | 246,450 | Jun 30, 2024 |
| ENGINEERS GATE MANAGER LP | 0.02% | 0.01% | 26,400 | 26,400 | 100.00% | 245,520 | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | 0.02% | 0.03% | 22,874 | 22,874 | 100.00% | 212,728 | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.02% | 0.00% | 22,727 | 22,727 | 100.00% | 211,000 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 0.02% | 0.00% | 18,762 | 18,762 | 100.00% | 174,487,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.02% | 0.00% | 18,557 | 18,557 | 100.00% | 172,580 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 0.02% | 0.00% | 17,500 | 17,500 | 100.00% | 162,750 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.01% | 0.00% | 16,174 | 16,174 | 100.00% | 150,418 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.01% | 0.06% | 12,426 | 12,426 | 100.00% | 115,561 | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | 0.01% | 0.01% | 11,772 | 11,772 | 100.00% | 109,480 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.00% | 10,800 | 10,800 | 100.00% | 100,440 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.01% | 0.00% | 10,415 | 10,415 | 100.00% | 97,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.04% | 9,692 | 9,692 | 100.00% | 90,136 | Jun 30, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 0.01% | 0.00% | 8,233 | 8,233 | 100.00% | 76,000 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | 0.01% | 0.04% | 8,113 | 8,113 | 100.00% | 75,451 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.09% | 6,572 | 6,572 | 100.00% | 61,120 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 2,319 | 2,319 | 100.00% | 21,567 | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 0.00% | 0.01% | 875 | 875 | 100.00% | 8,138 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 398 | 398 | 100.00% | 3,701 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.00% | - | 360 | 360 | 100.00% | 3,000 | Jun 30, 2024 |
Arcutis Biotherapeutics's largest new institutional shareholder by number of shares is CANDRIAM S.C.A., purchased 1.31M shares, valued at $12.16M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | - | - | - | -1,300,000 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -825,000 | -100.00% | - | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | - | - | - | -449,694 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -380,000 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -225,000 | -100.00% | - | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | - | - | - | -225,000 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -205,870 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -204,779 | -100.00% | - | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -139,211 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | - | - | - | -120,493 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -79,968 | -100.00% | - | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | - | - | - | -79,683 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -79,500 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -60,347 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -57,378 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -38,976 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -33,714 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -25,795 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -21,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -20,705 | -100.00% | - | Jun 30, 2024 |
| KOSHINSKI ASSET MANAGEMENT, INC. | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -17,000 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -12,200 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -11,100 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -10,675 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -6,452 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,431 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
Arcutis Biotherapeutics's largest sold out institutional shareholder by shares sold is BRAIDWELL LP, sold -1.30M shares, valued at -, as of undefined.
Arcutis Biotherapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Alger ETF Trust | 3.71% | 26,324 | - | - | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 1.63% | 3,389,514 | - | - | Feb 29, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.66% | 2,846,856 | 2,068,660 | 265.83% | Mar 28, 2024 |
| ALLSPRING VARIABLE TRUST | 0.42% | 261,446 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.39% | 243,205 | 64,953 | 36.44% | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.20% | 488,038 | 488,038 | - | Jan 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.18% | 1,539,452 | 250,632 | 19.45% | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.17% | 42,692 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.14% | 372,677 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.13% | 62,005 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.10% | 86,869 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.08% | 850,883 | -3,426 | -0.40% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.08% | 690,000 | - | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.08% | 392,902 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 35,006 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.06% | 151,900 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 440,089 | - | - | Jan 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.03% | 115,306 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,040 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 138,614 | 46,851 | 51.06% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 12,162 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 584,544 | - | - | Feb 29, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.02% | 162,505 | - | - | Feb 29, 2024 |
| HARBOR FUNDS | 0.02% | 349,210 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 945,942 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,508,866 | -1,098,755 | -19.59% | Mar 31, 2024 |
| AMG FUNDS | 0.01% | 310,981 | -27,400 | -8.10% | Mar 28, 2024 |
| Humankind Benefit Corp | 0.01% | 225 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.01% | 903,791 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,006 | -12,771 | -86.42% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 17,797 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.01% | 247,547 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 52,920 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 22,313 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 9,248 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 14,598 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 292,900 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 61,493 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.01% | 104,905 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 221,094 | 86,748 | 64.57% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 40,700 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 51,972 | -8,173 | -13.59% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 846,967 | 403,667 | 91.06% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 67,573 | -2,781 | -3.95% | Mar 31, 2024 |
| ProFunds | 0.00% | 42,370 | 41,704 | 6261.86% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 73,500 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 40,527 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,871 | 2,800 | 55.22% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 194,649 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 329,313 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 59,532 | 24,663 | 70.73% | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 11,488 | 11,432 | 20414.29% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 108,256 | - | - | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 85,339 | 85,339 | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 12,900 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 242,800 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 28,448 | 28,448 | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,805 | 2,229 | 386.98% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 900 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 26,156 | -67,056 | -71.94% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,795 | 1,197 | 46.07% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 444,581 | 191,726 | 75.82% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,492 | -208 | -2.39% | Mar 31, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 9,255 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 149,253 | - | - | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 5,604 | 5,604 | - | Mar 28, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 17,000 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 12,589 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 280,730 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 6,626 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 28,200 | -7,400 | -20.79% | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 36,358 | - | - | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,263 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 5,941 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 149 | - | - | Apr 30, 2021 |
| NORTHERN FUNDS | 0.00% | 39,567 | -2,432 | -5.79% | Mar 28, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 4,422 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 7,407 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,021 | 201 | 4.17% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,032 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 3,361,488 | -11,694 | -0.35% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 203,122 | - | - | Jan 31, 2024 |
| Harbor ETF Trust | 0.00% | 847 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 79,427 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 365,031 | 161,175 | 79.06% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 6,852,369 | 3,487,242 | 103.63% | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,746 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 196,300 | 9,881 | 5.30% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 706,760 | 13,100 | 1.89% | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 183 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 469 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 30,351 | 10,540 | 53.20% | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 9,661 | - | - | Mar 28, 2024 |
| Trust for Advised Portfolios | 0.00% | 2,030 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 2,800 | 1,300 | 86.67% | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,637 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 12,360 | 3,411 | 38.12% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,035 | 5,278 | 191.44% | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,758 | - | - | Dec 31, 2023 |
| MAINSTAY FUNDS TRUST | 0.00% | 17,123 | 17,123 | - | Jan 31, 2024 |
Arcutis Biotherapeutics's largest mutual fund holder by % of total assets is "Alger ETF Trust", owning 26.32K shares, compromising 3.71% of its total assets.
Arcutis Biotherapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 190 | 12.43% |
| 31 Mar, 24 | 169 | 24.26% |
| 31 Dec, 23 | 136 | -4.23% |
| 30 Sep, 23 | 142 | -3.40% |
| 30 Jun, 23 | 147 | - |
| 31 Mar, 23 | 147 | 1.38% |
| 31 Dec, 22 | 145 | 4.32% |
| 30 Sep, 22 | 139 | 18.80% |
| 30 Jun, 22 | 117 | 5.41% |
| 31 Mar, 22 | 111 | 20.65% |
| 31 Dec, 21 | 92 | -13.21% |
| 30 Sep, 21 | 106 | 0.95% |
| 30 Jun, 21 | 105 | 10.53% |
| 31 Mar, 21 | 95 | 21.79% |
| 31 Dec, 20 | 78 | 23.81% |
| 30 Sep, 20 | 63 | 12.50% |
| 30 Jun, 20 | 56 | 14.29% |
| 31 Mar, 20 | 49 | - |
As of 30 Jun 24, 190 institutions are holding Arcutis Biotherapeutics's shares, representing an increase of 12.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 126,433,878 | 1.32% |
| 31 Mar, 24 | 124,792,426 | 23.24% |
| 31 Dec, 23 | 101,262,581 | 51.01% |
| 30 Sep, 23 | 67,057,731 | -6.97% |
| 30 Jun, 23 | 72,085,565 | 0.64% |
| 31 Mar, 23 | 71,624,592 | 8.42% |
| 31 Dec, 22 | 66,063,042 | 11.41% |
| 30 Sep, 22 | 59,296,068 | 20.88% |
| 30 Jun, 22 | 49,054,525 | 1.52% |
| 31 Mar, 22 | 48,321,264 | 4.25% |
| 31 Dec, 21 | 46,350,235 | 1.48% |
| 30 Sep, 21 | 45,676,199 | 0.49% |
| 30 Jun, 21 | 45,453,482 | -2.92% |
| 31 Mar, 21 | 46,820,995 | 14.27% |
| 31 Dec, 20 | 40,973,756 | 17.86% |
| 30 Sep, 20 | 34,765,042 | 2.93% |
| 30 Jun, 20 | 33,776,856 | 3.34% |
| 31 Mar, 20 | 32,683,707 | - |
Arcutis Biotherapeutics (ARQT) has 126.43M shares outstanding as of 30 Jun 24, up 1.32% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.85% | 0.90% |
| 31 Mar, 24 | 112.38% | 0.53% |
| 31 Dec, 23 | 146.11% | 1.24% |
| 30 Sep, 23 | 108.64% | 0.79% |
| 30 Jun, 23 | 117.34% | 0.86% |
| 31 Mar, 23 | 117.09% | 0.81% |
| 31 Dec, 22 | 120.04% | 1.11% |
| 30 Sep, 22 | 103.86% | 1.14% |
| 30 Jun, 22 | 95.40% | 1.04% |
| 31 Mar, 22 | 95.66% | 1.09% |
| 31 Dec, 21 | 93.82% | 1.13% |
| 30 Sep, 21 | 91.17% | 1.10% |
| 30 Jun, 21 | 90.91% | 0.93% |
| 31 Mar, 21 | 99.03% | 1.32% |
| 31 Dec, 20 | 86.66% | 1.02% |
| 30 Sep, 20 | 92.10% | 1.14% |
| 30 Jun, 20 | 89.86% | 0.49% |
| 31 Mar, 20 | 134.74% | - |
As of 30 Jun 24, Arcutis Biotherapeutics is held by 113.85% institutional shareholders, representing a 0.90% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 107 | -1.83% |
| 31 Mar, 24 | 109 | 21.11% |
| 31 Dec, 23 | 90 | 28.57% |
| 30 Sep, 23 | 70 | -27.08% |
| 30 Jun, 23 | 96 | 9.09% |
| 31 Mar, 23 | 88 | -6.38% |
| 31 Dec, 22 | 94 | -9.62% |
| 30 Sep, 22 | 104 | 46.48% |
| 30 Jun, 22 | 71 | 24.56% |
| 31 Mar, 22 | 57 | 9.62% |
| 31 Dec, 21 | 52 | 33.33% |
| 30 Sep, 21 | 39 | -39.06% |
| 30 Jun, 21 | 64 | - |
| 31 Mar, 21 | 64 | 12.28% |
| 31 Dec, 20 | 57 | 35.71% |
| 30 Sep, 20 | 42 | 31.25% |
| 30 Jun, 20 | 32 | -34.69% |
| 31 Mar, 20 | 49 | - |
107 institutional shareholders have increased their position in ARQT stock as of 30 Jun 24 compared to 109 in the previous quarter (a -1.83% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 55 | 44.74% |
| 31 Mar, 24 | 38 | 46.15% |
| 31 Dec, 23 | 26 | -31.58% |
| 30 Sep, 23 | 38 | 46.15% |
| 30 Jun, 23 | 26 | -23.53% |
| 31 Mar, 23 | 34 | 30.77% |
| 31 Dec, 22 | 26 | 52.94% |
| 30 Sep, 22 | 17 | -22.73% |
| 30 Jun, 22 | 22 | -24.14% |
| 31 Mar, 22 | 29 | 70.59% |
| 31 Dec, 21 | 17 | -48.48% |
| 30 Sep, 21 | 33 | 37.50% |
| 30 Jun, 21 | 24 | 33.33% |
| 31 Mar, 21 | 18 | 50.00% |
| 31 Dec, 20 | 12 | 20.00% |
| 30 Sep, 20 | 10 | -9.09% |
| 30 Jun, 20 | 11 | - |
| 31 Mar, 20 | - | - |
55 institutional shareholders have reduced their position in ARQT stock as of 30 Jun 24 compared to 38 in the previous quarter (a 44.74% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 190 | 12.43% | 126,433,878 | 1.32% | 113.85% | 0.90% | 107 | -1.83% | 55 | 44.74% |
| 31 Mar, 24 | 169 | 24.26% | 124,792,426 | 23.24% | 112.38% | 0.53% | 109 | 21.11% | 38 | 46.15% |
| 31 Dec, 23 | 136 | -4.23% | 101,262,581 | 51.01% | 146.11% | 1.24% | 90 | 28.57% | 26 | -31.58% |
| 30 Sep, 23 | 142 | -3.40% | 67,057,731 | -6.97% | 108.64% | 0.79% | 70 | -27.08% | 38 | 46.15% |
| 30 Jun, 23 | 147 | - | 72,085,565 | 0.64% | 117.34% | 0.86% | 96 | 9.09% | 26 | -23.53% |
| 31 Mar, 23 | 147 | 1.38% | 71,624,592 | 8.42% | 117.09% | 0.81% | 88 | -6.38% | 34 | 30.77% |
| 31 Dec, 22 | 145 | 4.32% | 66,063,042 | 11.41% | 120.04% | 1.11% | 94 | -9.62% | 26 | 52.94% |
| 30 Sep, 22 | 139 | 18.80% | 59,296,068 | 20.88% | 103.86% | 1.14% | 104 | 46.48% | 17 | -22.73% |
| 30 Jun, 22 | 117 | 5.41% | 49,054,525 | 1.52% | 95.40% | 1.04% | 71 | 24.56% | 22 | -24.14% |
| 31 Mar, 22 | 111 | 20.65% | 48,321,264 | 4.25% | 95.66% | 1.09% | 57 | 9.62% | 29 | 70.59% |
| 31 Dec, 21 | 92 | -13.21% | 46,350,235 | 1.48% | 93.82% | 1.13% | 52 | 33.33% | 17 | -48.48% |
| 30 Sep, 21 | 106 | 0.95% | 45,676,199 | 0.49% | 91.17% | 1.10% | 39 | -39.06% | 33 | 37.50% |
| 30 Jun, 21 | 105 | 10.53% | 45,453,482 | -2.92% | 90.91% | 0.93% | 64 | - | 24 | 33.33% |
| 31 Mar, 21 | 95 | 21.79% | 46,820,995 | 14.27% | 99.03% | 1.32% | 64 | 12.28% | 18 | 50.00% |
| 31 Dec, 20 | 78 | 23.81% | 40,973,756 | 17.86% | 86.66% | 1.02% | 57 | 35.71% | 12 | 20.00% |
| 30 Sep, 20 | 63 | 12.50% | 34,765,042 | 2.93% | 92.10% | 1.14% | 42 | 31.25% | 10 | -9.09% |
| 30 Jun, 20 | 56 | 14.29% | 33,776,856 | 3.34% | 89.86% | 0.49% | 32 | -34.69% | 11 | - |
| 31 Mar, 20 | 49 | - | 32,683,707 | - | 134.74% | - | 49 | - | - | - |
Arcutis Biotherapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Arcutis Biotherapeutics's stock was made by Matsuda Masaru on Aug 05 2024, selling 5,220 shares at $9.02 per share (valued at $47.06K).
Arcutis Biotherapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 3 | 66.67% |
| Q2 2024 | 24 | 14 | 171.43% |
| Q1 2024 | 29 | 22 | 131.82% |
| Q4 2023 | 4 | 4 | 100.00% |
| Q3 2023 | 4 | 6 | 66.67% |
| Q2 2023 | 21 | 5 | 420.00% |
| Q1 2023 | 18 | 38 | 47.37% |
| Q4 2022 | 2 | 7 | 28.57% |
| Q3 2022 | 6 | 13 | 46.15% |
| Q2 2022 | 19 | 22 | 86.36% |
| Q1 2022 | 25 | 29 | 86.21% |
| Q4 2021 | 9 | 15 | 60.00% |
| Q3 2021 | 9 | 16 | 56.25% |
| Q2 2021 | 28 | 44 | 63.64% |
| Q1 2021 | 36 | 53 | 67.92% |
| Q4 2020 | 18 | 22 | 81.82% |
| Q3 2020 | 14 | 20 | 70.00% |
| Q2 2020 | 2 | 1 | 200.00% |
| Q1 2020 | 47 | 49 | 95.92% |
2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by Arcutis Biotherapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 10 | - |
| Q1 2024 | 1 | 6 | 16.67% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | - | 2 | - |
| Q2 2023 | 1 | 3 | 33.33% |
| Q1 2023 | - | 36 | - |
| Q4 2022 | - | 6 | - |
| Q3 2022 | 2 | 8 | 25.00% |
| Q2 2022 | - | 18 | - |
| Q1 2022 | - | 21 | - |
| Q4 2021 | - | 8 | - |
| Q3 2021 | - | 7 | - |
| Q2 2021 | - | 19 | - |
| Q1 2021 | - | 30 | - |
| Q4 2020 | 4 | 9 | 44.44% |
| Q3 2020 | - | 8 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 7 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Arcutis Biotherapeutics's stocks.
Arcutis Biotherapeutics Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| APLS | Apellis Pharmaceuticals, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| ERAS | Erasca, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| INZY | Inozyme Pharma, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| MIRM | Mirum Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
ARQT Ownership FAQ
Who Owns Arcutis Biotherapeutics?
Arcutis Biotherapeutics is owned by institutional shareholders (113.85%), insiders (2.20%), and public (-16.05%). The largest institutional shareholder of Arcutis Biotherapeutics is JENNISON ASSOCIATES LLC (10.42% of total shares) and the top mutual fund owner is Alger ETF Trust (3.71% of total shares).
Who are the major institutional shareholders of Arcutis Biotherapeutics?
Arcutis Biotherapeutics's major institutional shareholders are JENNISON ASSOCIATES LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, RUBRIC CAPITAL MANAGEMENT LP, FRAZIER LIFE SCIENCES MANAGEMENT, L.P., and BLACKROCK INC.. The top five shareholders own together 43.95% of the company's share outstanding.
How many Arcutis Biotherapeutics shareholders are there?
As of Jun 2024, there are 190 institutional shareholders of Arcutis Biotherapeutics.
What percentage of Arcutis Biotherapeutics is owned by JENNISON ASSOCIATES LLC?
JENNISON ASSOCIATES LLC owns 11.57M shares of Arcutis Biotherapeutics, representing 10.42% of the company's total shares outstanding, valued at $107.62M (as of Jun 2024).
What percentage of Arcutis Biotherapeutics is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
As of Jun 2024, SUVRETTA CAPITAL MANAGEMENT, LLC holds 10M shares of Arcutis Biotherapeutics (ARQT), compromising 9.01% of the company, valued at $93.04M.
What percentage of Arcutis Biotherapeutics is owned by RUBRIC CAPITAL MANAGEMENT LP?
RUBRIC CAPITAL MANAGEMENT LP is the third largest holder of Arcutis Biotherapeutics. The company owns 9.82M of the company's shares outstanding (worth $91.3M).